Parallel Advisors, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Parallel Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$10.11 - $16.54 $1,880 - $3,076	-186 Reduced 75.0%	62 $1,000
Q1 2023 May 20, 2024	BUY	$14.26 - $22.1 $2,652 - $4,110	186 Added 300.0%	248 $3,000
Q4 2022 Feb 03, 2023	SELL	$14.85 - $19.04 $103 - $133	-7 Reduced 2.75%	248 $4,000
Q3 2022 Nov 10, 2022	BUY	$12.38 - $20.23 $86 - $141	7 Added 2.82%	255 $5,000
Q2 2022 Aug 01, 2022	BUY	$9.11 - $13.98 $1,958 - $3,005	215 Added 651.52%	248 $3,000
Q1 2022 Apr 28, 2022	SELL	$6.87 - $11.11 $4,403 - $7,121	-641 Reduced 95.1%	33 $0
Q4 2021 Jan 20, 2022	BUY	$7.7 - $37.13 $4,519 - $21,795	587 Added 674.71%	674 $7,000
Q3 2021 Nov 02, 2021	BUY	$26.46 - $37.15 $2,037 - $2,860	77 Added 770.0%	87 $3,000
Q2 2021 Aug 06, 2021	SELL	$32.73 - $47.95 $818 - $1,198	-25 Reduced 71.43%	10 $0
Q1 2021 Apr 23, 2021	BUY	$40.39 - $56.73 $1,009 - $1,418	25 Added 250.0%	35 $2,000
Q4 2020 Feb 02, 2021	SELL	$51.77 - $66.18 $1,553 - $1,985	-30 Reduced 75.0%	10 $1,000
Q3 2020 Oct 27, 2020	SELL	$43.8 - $58.16 $1,226 - $1,628	-28 Reduced 41.18%	40 $2,000
Q2 2020 Jul 16, 2020	BUY	$37.05 - $65.03 $2,519 - $4,422	68 New	68 $4,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.